MEDizzy
MEDizzy
USMLE
Combined Hematology
A 71-year-old woman with no significant past medical history is investigated for lymphocytosis. She has recently lost 7kg in weight and complains of lethargy. The following blood results are obtained: Hb 9.8 g/dl Plt 104 * 109/l WBC 70.3 * 109/l Blood film: Lymphocytosis. Smudge cells seen Four months previously her white cell count was 30.5 * 109/l. What is the most appropriate management?
Explanation
ExplanationD. CLL - treatment: Fludarabine, Cyclophosphamide and Rituximab (FCR) This patient has chronic lymphocytic leukemia. The lymphocyte doubling time is less than 6 months, the patient has some evidence of marrow failure and also has systemic symptoms. She should therefore be treated and of the options given a combination of fludarabine, cyclophosphamide and rituximab (FCR) is the most appropriate treatment. Chlorambucil used to be the first-line treatment of choice but studies have shown it not to be as effective as FCR. As with many hematological cancers such patients are often entered into randomized trials
USMLE
More questions